Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran
Abstract The Sputnik V is a COVID- 19 vaccine developed by the Gamalia institute of epidemiology and microbiology and released on August 11, 2020. We provided independent evidence on side effects and immunogenicity following the administration of the Sputnik V COVID-19 in Iran. In this observational...
Guardado en:
Autores principales: | Farhang Babamahmoodi, Majid Saeedi, Reza Alizadeh-Navaei, Akbar Hedayatizadeh-Omran, Seyed Abbas Mousavi, Gasem Ovaise, Shirafkan Kordi, Zahra Akbari, Mazaher Azordeh, Fatemeh Ahangarkani, Ahmad Alikhani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0971570018154763af5766e40f50aa52 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults
por: Amir I. Tukhvatulin, et al.
Publicado: (2021) -
Relationship between Reproductive Factor and Breast Cancer in Mazandaran Cohort: A Case-Control Study
por: M Moosazadeh, et al.
Publicado: (2020) -
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
por: Satoshi Ikegame, et al.
Publicado: (2021) -
Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina
por: Rossana Elena Chahla, et al.
Publicado: (2022) -
Shedding light on biochemical features and potential immunogenic epitopes of Neospora caninum SAG1: In silico study
por: Morteza Shams, et al.
Publicado: (2021)